Evidence map›Paper›PMID 27517874›Full record

ArticlePloS one2016

NF-Y Binding Site Architecture Defines a C-Fos Targeted Promoter Class.

Martin Haubrock, Fabian Hartmann, Edgar Wingender

Abstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. On the NF-Y regulome as in ENCODE (2019).PLoS computational biology · 2020
    Article
  2. Article
  3. Article
  4. The Plant NF-Y DNA MatrixPlants (Basel, Switzerland) · 2019
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Martin HaubrockInstitute of Bioinformatics, University Medical Center Göttingen (UMG), Georg-August-University Göttingen, Goldschmidtstrasse 1, 37077 Göttingen, Germany.
Fabian HartmannInstitute of Bioinformatics, University Medical Center Göttingen (UMG), Georg-August-University Göttingen, Goldschmidtstrasse 1, 37077 Göttingen, Germany.
Edgar WingenderInstitute of Bioinformatics, University Medical Center Göttingen (UMG), Georg-August-University Göttingen, Goldschmidtstrasse 1, 37077 Göttingen, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

ChIP-seq experiments detect the chromatin occupancy of known transcription factors in a genome-wide fashion. The comparisons of several species-specific ChIP-seq libraries done for different transcription factors have revealed a complex combinatorial and context-specific co-localization behavior for the identified binding regions. In this study we have investigated human derived ChIP-seq data to identify common cis-regulatory principles for the human transcription factor c-Fos. We found that in four different cell lines, c-Fos targeted proximal and distal genomic intervals show prevalences for either AP-1 motifs or CCAAT boxes as known binding motifs for the transcription factor NF-Y, and thereby act in a mutually exclusive manner. For proximal regions of co-localized c-Fos and NF-YB binding, we gathered evidence that a characteristic configuration of repeating CCAAT motifs may be responsible for attracting c-Fos, probably provided by a nearby AP-1 bound enhancer. Our results suggest a novel regulatory function of NF-Y in gene-proximal regions. Specific CCAAT dimer repeats bound by the transcription factor NF-Y define this novel cis-regulatory module. Based on this behavior we propose a new enhancer promoter interaction model based on AP-1 motif defined enhancers which interact with CCAAT-box characterized promoter regions.

Indexed as

Promoter Regions, GeneticAmino Acid MotifsAmino Acid SequenceBinding SitesCCAAT-Binding FactorCell Line, TumorDimerizationHumansModels, Molecularp300-CBP Transcription FactorsProto-Oncogene Proteins c-fosTranscription Factor AP-1CCAAT-Binding Factorp300-CBP Transcription FactorsProto-Oncogene Proteins c-fosTranscription Factor AP-1

Identifiers

PMID27517874
PMCPMC4982600

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.